Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

Roberts in-licenses another GI drug from Lilly

Dec. 10, 1996

Successful phase III results reported for British Biotech PAF antagonist

Dec. 9, 1996

Cytel to implement new development strategy for HBV vaccine

Dec. 6, 1996

Phase IIa trial on Isis antiinflammatory antisense compound completed

Dec. 5, 1996

Axcan-Schwarz joint venture to market URSO

Dec. 2, 1996

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Nov. 26, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

New market introduction for proton pump inhibitor

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...